Therapeutic approaches to the management of herpes zoster.
The past several years have provided exciting advances in the management of herpes zoster in the normal host. In spite of these advances, a significant portion of zoster patients still have persistent complications from this disease. Persistent pain is the most debilitating sequela and it occurs in at least 15% of individuals over 50 years of age. Future research efforts must embrace alternative approaches for pain control.
Whitley
R J
RJ
Department of Pediatrics, Microbiology and Medicine, University of Alabama at Birmingham 35233-0011, USA.
Gnann
J W
JW
D015075:2-Aminopurine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000212:Acyclovir / Q000031:analogs & derivatives / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D000077595:Famciclovir; D006562:Herpes Zoster / Q000188:drug therapy* / Q000503:physiopathology*; D006801:Humans; D010146:Pain; D011241:Prednisone / Q000627:therapeutic use; D011355:Prodrugs / Q000627:therapeutic use; D000077483:Valacyclovir; D014633:Valine / Q000031:analogs & derivatives / Q000627:therapeutic use
D000998:Antiviral Agents; D011355:Prodrugs; D015075:2-Aminopurine; D014633:Valine; D000077483:Valacyclovir; D000077595:Famciclovir; D011241:Prednisone; D000212:Acyclovir